Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.14 USD -0.34% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bicycle Therapeutics PLC
Cash Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Cash Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash
$890.9m
CAGR 3-Years
51%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash
$128m
CAGR 3-Years
161%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Cash
ÂŁ257.6m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash
$239.6m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash
ÂŁ42.5m
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is Bicycle Therapeutics PLC's Cash?
Cash
890.9m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Cash amounts to 890.9m USD.

What is Bicycle Therapeutics PLC's Cash growth rate?
Cash CAGR 5Y
56%

Over the last year, the Cash growth was 56%. The average annual Cash growth rates for Bicycle Therapeutics PLC have been 51% over the past three years , 56% over the past five years .

Back to Top